Atlas Trials

A Study to Observe the Long-term Safety of Odevixibat in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment

Clinical trial NCT07585097 · RECRUITING

Trial details

NCT number
NCT07585097
Sponsor
Ipsen
Status
RECRUITING
Study type
OBSERVATIONAL
Alagille Syndrome
Start date
2026-07-10
Primary completion
2031-09-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.